| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,771 |
5,763 |
$2.20M |
| J9035 |
Injection, bevacizumab, 10 mg |
6,676 |
4,423 |
$515K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,095 |
3,404 |
$182K |
| 92020 |
|
2,984 |
2,889 |
$59K |
| 92226 |
|
1,447 |
1,048 |
$58K |
| 92202 |
|
2,145 |
2,040 |
$55K |
| J7999 |
Compounded drug, not otherwise classified |
1,128 |
773 |
$52K |
| 92134 |
|
1,330 |
1,296 |
$19K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,092 |
1,077 |
$17K |
| J0178 |
Injection, aflibercept, 1 mg |
39 |
27 |
$13K |
| 67228 |
|
34 |
24 |
$8K |
| 67210 |
|
23 |
14 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
755 |
484 |
$3K |
| 92235 |
|
16 |
14 |
$2K |
| 92250 |
|
15 |
15 |
$682.86 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19 |
19 |
$672.72 |